News Stories

Nov, 2023

Nominations open November 15, 2023, for the National Lipid Association Board of Directors and Chapter officers and has been extended until 5 p.m. EST on February 16, 2024.

To submit a nomination and for more information on the process, visit lipid.org/nominate.

0
No votes yet
Name: Top Stories
Sep, 2023

 

  • Olezarsen met the primary endpoint with a statistically significant reduction in triglyceride levels versus placebo
  • First study to show an absolute reduction in acute pancreatitis in FCS patients, with olezarsen 80 mg monthly dose reducing events by 100 percent 
  • Olezarsen demonstrated a favorable safety and tolerability profile
  • Ionis plans to file a New Drug Application with U.S. FDA in preparation for first potential independent launch

0
No votes yet
Name: NLA News
Sep, 2023

The United States Preventive Services Task Force (USPSTF) recently released its Final Recommendation Statement on Lipid Disorders in Children and Adolescents: Screening. NLA leadership disagrees with this release and communicated twice to USPSTF about the implications of this statement. The USPSTF has made no acknowledgment of the NLA’s concerns.

0
No votes yet
Name: NLA News